| Overview |
| bsm-90147r-50µL |
| Lysine acetyltransferase 7 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human KAT7 / HBO1 / MYST2 |
| 1-230/611 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 11143 |
| O95251 |
| KAT7; Lysine Acetyltransferase 7; HBO1; Histone Acetyltransferase Binding To ORC1; ZC2HC7; MYST2; HBOA; MOZ YBF2/SAS3 SAS2 And TIP60 Protein; MYST Histone Acetyltransferase 2; Histone Acetyltransferase KAT7; K(Lysine) Acetyltransferase 7; Histone Acetyltransferase MYST2; EC 2.3.1.48; MYST-2; HBOa |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |